Open AccessAutoimmune Thrombocytopenia in SLE and COVID-19
Author(s) -
Yeremia Suryo Pratama,
Riska Pradiptakirana,
Azkia Rachmah,
Nurhasan Agung Prabowo
Publication year - 2021
Publication title -
european journal of case reports in internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2284-2594
DOI - 10.12890/2021_002863
Subject(s) - medicine , covid-19 , systemic lupus erythematosus , autoimmune thrombocytopenia , pathophysiology , disease , autoimmune disease , lupus erythematosus , immunology , hydroxychloroquine , pediatrics , platelet , virology , infectious disease (medical specialty) , antibody , outbreak
Thrombocytopenia and hypercoagulopathy are haematological abnormalities commonly seen in individuals with coronavirus disease 2019 (COVID-19) and systemic lupus erythematosus (SLE). The difficulty arises when the patient has both diseases concurrently. The clinician should be able to comprehend the pathophysiology of these patient abnormalities in order to provide the best treatment possible. We present a case of a 20-year-old female COVID-19 patient with a history of SLE who had thrombocytopenia but normal D-dimer results. Our analysis revealed that the thrombocytopenia may have been caused by a relapse of lupus, not by COVID-19 infection. In this case, glucocorticoids were the primary therapy and produced excellent results.